Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Value of Screening for "High on Treatment Platelet Reactivity" in Patients Undergoing Lower Extremity Arterial Endovascular Interventions

NCT04007055 is registered in ClinicalTrials.gov with Marissa Jarosinski as lead sponsor.

NCT NCT04007055
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04007055 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Value of Screening for "High on Treatment Platelet Reactivity" in Patients Undergoing Lower Extremity Arterial Endovascular Interventions
Lead sponsor
Marissa Jarosinski
Phase
Phase 3
Overall status
Terminated
Start date
August 9, 2019
Completion date
March 28, 2024
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

artery disease, clopidogrel, poor metabolism of, peripheral arterial occlusive disease, peripheral artery disease, peripheral vascular disease